Arnaud C Tiberghien (Arnaud Tiberghien)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Diffusion Weighted

Magnetic Resonance

Top Venues

Molecular cancer therapeutics

PLoS neglected tropical diseases

Scientific reports

The Journal of organic chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Arnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, Mahammad Ahmed, Raul Pardo, John Bingham, Lauren Adams, Kathleen Santos, Gyoung-Dong Kang, Kathryn M Pugh, Shameen Afif-Rider, Kapil Vashisht, Kemal Haque, Ravinder Tammali, Edward Rosfjord, Adriana Savoca, John A Hartley, Philip W Howard
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and Toxicity. Molecular cancer therapeutics 22 (2) (2023)
Arnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, Mahammad Ahmed, Raul Pardo, John Bingham, Lauren Adams, Kathleen Santos, Gyoung-Dong Kang, Kathryn M Pugh, Shameen Afif-Rider, Kapil Vashisht, Kemal Haque, Ravinder Tammali, Edward Rosfjord, Adriana Savoca, John A Hartley, Philip W Howard
Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and Toxicity. Molecular cancer therapeutics 22 (2) (2023)
Arnaud C Tiberghien, Balakumar Vijayakrishnan, Arman Esfandiari, Mahammad Ahmed, Raul Pardo, John Bingham, Lauren Adams, Kathleen Santos, Gyoung-Dong Kang, Kathryn M Pugh, Shameen Afif-Rider, Kapil Vashisht, Kemal Haque, Ravinder Tammali, Edward Rosfjord, Adriana Savoca, John A Hartley, Philip W Howard
Comparison of pyrrolobenzodiazepine dimer bis-imine versus mono-imine: DNA interstrand cross-linking, cytotoxicity, and antibody-drug conjugate efficacy and toxicity. Molecular cancer therapeutics (2022)
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, Elaine M Hurt, Suneetha B Thomas, Vanessa Muniz-Medina, Christopher Ward, Agnieszka Sadowska, Ryan Fleming, Subramanya Karanth, Shannon Breen, Bo Zheng, Yuling Wu, William O Iverson, Steven J Novick, Terrence O'Day, Dipesha P Shah, Nazzareno Dimasi, Arnaud C Tiberghien, Jane Osbourn, Jill Walker
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells. Molecular cancer therapeutics 19 (8) (2020)
Arnaud C Tiberghien, Philip W Howard, William R F Goundry, Marc McCormick, Jeremy S Parker
An Alternative Focus for Route Design for the Synthesis of Antibody-Drug Conjugate Payloads. The Journal of organic chemistry 84 (8) (2019)
Qing Li, Allison Barrett, Balakumar Vijayakrishnan, Arnaud C Tiberghien, Rhiannon Beard, Keith W Rickert, Kevin L Allen, R Jim Christie, Marcello Marelli, Jay Harper, Philip Howard, Herren Wu, William F Dall'Acqua, Ping Tsui, Changshou Gao, M Jack Borrok
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension. Bioconjugate chemistry 30 (4) (2019)
Paula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, Martin C Taylor, Steven Rust, Alan M Sandercock, Olivia J S Macleod, Katrien Van Bocxlaer, Amanda F Francisco, Francois D'Hooge, Arnaud C Tiberghien, Conor S Barry, Philip Howard, Matthew K Higgins, Tristan J Vaughan, Ralph Minter, Mark Carrington
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasis. PLoS neglected tropical diseases 13 (5) (2019)
Krista Kinneer, John Meekin, Arnaud C Tiberghien, Yu-Tzu Tai, Sandrina Phipps, Christine Mione Kiefer, Marlon C Rebelatto, Nazzareno Dimasi, Alyssa Moriarty, Kyriakos P Papadopoulos, Sriram Sridhar, Stephen J Gregson, Michael J Wick, Luke Masterson, Kenneth C Anderson, Ronald Herbst, Philip W Howard, David A Tice
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
John A Hartley, Michael J Flynn, John P Bingham, Simon Corbett, Halla Reinert, Arnaud C Tiberghien, Luke A Masterson, Dyeison Antonow, Lauren Adams, Sajidah Chowdhury, David G Williams, Shenlan Mao, Jay Harper, Carin E G Havenith, Francesca Zammarchi, Simon Chivers, Patrick H van Berkel, Philip W Howard
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine. Scientific reports 8 (1) (2018)